Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer

Lutetium-177-PSMA ([177Lu]-PSMA-617), a radiolabeled small molecule, binds with high affinity to prostate-specific membrane antigen (PSMA), enabling targeted radiation therapy to metastatic prostate lesions. Our objective was to retrospectively analyze the activity of [177Lu]-PSMA-617 given off-tria...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Gadot, Moran, Davidson, Tima, Aharon, Margalit, Atenafu, Eshetu G., Malki, Avraham, Levartovsky, Meital, Saad, Akram, Domachevsky, Liran, Berger, Raanan, Leibowitz, Raya
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281592/
https://ncbi.nlm.nih.gov/pubmed/32357427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051078
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires